Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$187.64 - $206.25 $271,139 - $298,031
-1,445 Reduced 18.42%
6,399 $1.23 Million
Q1 2023

Aug 14, 2023

BUY
$127.59 - $203.08 $184,367 - $293,450
1,445 Added 22.58%
7,844 $1.59 Million
Q1 2023

May 15, 2023

SELL
$127.59 - $203.08 $1.41 Million - $2.24 Million
-11,038 Reduced 58.46%
7,844 $1.59 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $16,197 - $19,205
-138 Reduced 0.73%
18,882 $2.43 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $61,547 - $81,950
-455 Reduced 2.34%
19,020 $2.6 Million
Q2 2022

Aug 11, 2022

SELL
$108.81 - $179.33 $62,348 - $102,756
-573 Reduced 2.86%
19,475 $3.45 Million
Q1 2022

May 16, 2022

SELL
$119.61 - $157.85 $8,133 - $10,733
-68 Reduced 0.34%
20,048 $2.89 Million
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $42,913 - $57,448
-301 Reduced 1.47%
20,116 $3.11 Million
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $37,037 - $44,153
-260 Reduced 1.26%
20,417 $3.47 Million
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $11,076 - $13,210
-82 Reduced 0.4%
20,677 $3.26 Million
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $16,501 - $22,896
-120 Reduced 0.57%
20,759 $2.88 Million
Q4 2020

Feb 17, 2021

BUY
$164.63 - $211.93 $3.44 Million - $4.42 Million
20,879 New
20,879 $3.66 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.